ישראל - עברית - Ministry of Health

a.veterinary supply ltd - fenbendazole 500 mg; praziquantel 50 mg - tablets - for the treatment of combined infections with round and tapeworms in dogs and cats: ascarids : toxocara canis, toxascaris leonine. hookworms: uncinaria stenocephala, ancylostoma caninum. whipworms: triichuris vulpis. tapeworms:echinococus granulosis, echinococcus multilocularis, dipylidium caninum, taenia spp., multiceps, mesocestoides spp. the treatment with vermisex vet., due to the diagnosis of a combined infection, is indicated only after the third week of life in newborn puppies.

ישראל - עברית - Ministry of Health

lidorr elements ltd - imidacloprid; moxidectin - תמיסה - imidacloprid 100 mg/ml; moxidectin 25 mg/ml - for dogs suffering from or at risk from mixed parasitic infections : for the treatment and prevention of flea infestation (ctenocephalides felis) treatment of biting lice (trichodectes canis) treatment of ear mit infestation (otodectes cynotis) sarcoptic mange (caused by sarcoptes scabiei var. canys) demodicosis ( caused by demodex canis) prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis) treatment of angiostrongylus vasorum adn treatment of infections with gastrointestinal nematodes (l4 larve immature adults and adults of toxocara canis ancylostoma caninum and uncinaria stenocephala adults of toxascaris leonina and trichuris vulpis). the product can be used as part of a treatment strategy for flea allergy dermatitis (fad).

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - oxantel as embonate; praziquantel; pyrantel embonate - טבליה - oxantel as embonate 200.28 mg; pyrantel embonate 49.94 mg; praziquantel 50 mg - for curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematodes and cestode species : nemtodes : toxocara canis toxocaris leonine ancylostoma caninum uncinaria stenocephala trichuris vulpis. cestodes : dipylidum caninum taenia spp.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - oxantel as embonate; praziquantel; pyrantel embonate - טבליה - oxantel as embonate 500.7 mg; pyrantel embonate 124.85 mg; praziquantel 125 mg - for curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematodes and cestode species : nemtodes : toxocara canis toxocaris leonine ancylostoma caninum uncinaria stenocephala trichuris vulpis. cestodes : dipylidum caninum taenia spp.

ישראל - עברית - Ministry of Health

lidorr elements ltd - febantel; praziquantel; pyrantel embonate - טבליה - praziquantel 50 mg; febantel 150 mg; pyrantel embonate 144 mg

ישראל - עברית - Ministry of Health

lidorr elements ltd - febantel; pyrantel embonate - תרחיף - febantel 1.5 g / 100 ml; pyrantel embonate 1.44 g / 100 ml

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - vinorelbine as tartrate - קפסולות - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 1200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.